Status:

COMPLETED

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Lead Sponsor:

Cordis US Corp.

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

This is a single center, non-randomized study. Patients will be treated with the sirolimus coated Bx VELOCITY Balloon-Expandable Stent mounted on the Raptor OTW SDS. Patients will have a repeat angiog...

Detailed Description

This is a single center, non-randomized study of the Bx VELOCITY Balloon-Expandable Stent coated with sirolimus (140µg/cm2) and formulated for fast or slow release. The sirolimus coated stent is mount...

Eligibility Criteria

Inclusion

  • Diagnosis of angina pectoris as defined by Canadian Cardiovascular Society Classification (CCS) or a positive ischemia study;
  • Single de novo or restenotic lesion requiring treatment in a major native coronary artery;
  • Target lesion is \<=18mm in length (visual estimate);
  • Target lesion is \>=3.0mm and \<=3.5mm in diameter (visual estimate);
  • Target lesion stenosis is \>50% and \<100% (visual estimate);

Exclusion

  • A Q-wave or non-Q-wave myocardial infarction within the preceding 72 hours unless the CK and CK-MB enzymes are back to normal;
  • Unprotected left main coronary disease with \>=50% stenosis;
  • Have an ostial target lesion;
  • Angiographic evidence of thrombus within target lesion;
  • Calcified lesions which cannot be successfully predilated;
  • Ejection fraction \<=30%;
  • Target lesion involves bifurcation (either stenosis of both main vessel and major branch or stenosis of just major branch);
  • Totally occluded vessel;

Key Trial Info

Start Date :

December 1 1999

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2005

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00233792

Start Date

December 1 1999

End Date

March 1 2005

Last Update

October 12 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Instituto Dante Pazzanese of Cardiology

São Paulo, Brazil, 04012-909